• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hybritech Tandem-R检测法与雅培AxSYM检测法在血清前列腺特异性抗原测量方面的可比性。

Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.

作者信息

Leewansangtong S, Goktas S, Lepoff R, Holthaus K, Crawford E D

机构信息

Division of Urology, University of Colorado Health Sciences Center, Denver 80262, USA.

出版信息

Urology. 1998 Sep;52(3):467-9. doi: 10.1016/s0090-4295(98)00210-6.

DOI:10.1016/s0090-4295(98)00210-6
PMID:9730462
Abstract

OBJECTIVES

To assess the comparability of the Hybritech Tandem-R and Abbott AxSYM PSA assays in the setting of a hospital laboratory changing methods of PSA assay.

METHODS

A total of 115 serum samples were tested simultaneously with both reagent kits. These include samples from patients evaluated for screening, benign prostatic hyperplasia, and follow-up of prostate cancer.

RESULTS

The outcomes of the Hybritech Tandem-R PSA test ranged from 0.0 to 48.3 ng/mL with a median value of 2.4 ng/mL (mean 3.48, SD 5.46). The outcomes of the Abbott AxSYM PSA test ranged from 0.0 to 49.33 ng/mL with a median of 2.22 ng/mL (mean 3.82, SD 5.59). The outcomes of the two assays were found to be highly correlated by the Pearson correlation coefficient (r = 0.9942). When samples were divided according to PSA levels of 0.0 to less than 2.5, 2.5 to less than 4.0, 4.0 to less than 10.0, and 10.0 to less than 25.0 ng/mL, the outcomes were also highly correlated in all PSA level ranges (r = 0.9619, 0.8094, 0.9167, and 0.9081, respectively).

CONCLUSIONS

The PSA values of the Tandem-R and Abbott AxSYM assays are highly correlated in the PSA level ranges of 0.0 to less than 2.5, 2.5 to less than 4.0, 4.0 to less than 10.0, and 10.0 to less than 25.0 ng/mL.

摘要

目的

在一家医院实验室更换前列腺特异性抗原(PSA)检测方法的背景下,评估Hybritech Tandem - R和雅培AxSYM PSA检测方法的可比性。

方法

使用两种试剂盒同时检测115份血清样本。这些样本包括来自接受筛查、良性前列腺增生评估以及前列腺癌随访的患者。

结果

Hybritech Tandem - R PSA检测结果范围为0.0至48.3 ng/mL,中位数为2.4 ng/mL(均值3.48,标准差5.46)。雅培AxSYM PSA检测结果范围为0.0至49.33 ng/mL,中位数为2.22 ng/mL(均值3.82,标准差5.59)。经皮尔逊相关系数分析发现,两种检测结果高度相关(r = 0.9942)。当根据PSA水平分为0.0至小于2.5、2.5至小于4.0、4.0至小于10.0以及10.0至小于25.0 ng/mL进行分组时,在所有PSA水平范围内结果也高度相关(分别为r = 0.9619、0.8094、0.9167和0.9081)。

结论

在PSA水平范围为0.0至小于2.5、2.5至小于4.0、4.0至小于10.0以及10.0至小于25.0 ng/mL时,Tandem - R和雅培AxSYM检测的PSA值高度相关。

相似文献

1
Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.Hybritech Tandem-R检测法与雅培AxSYM检测法在血清前列腺特异性抗原测量方面的可比性。
Urology. 1998 Sep;52(3):467-9. doi: 10.1016/s0090-4295(98)00210-6.
2
Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
Urol Int. 1998;60(1):25-7. doi: 10.1159/000030198.
3
The variation of percent free prostate-specific antigen determined by two different assays.
Anticancer Res. 2003 Jan-Feb;23(1B):707-11.
4
Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.三种血清总前列腺特异性抗原及游离前列腺特异性抗原百分比检测方法在预测前列腺组织学方面的比较
Urology. 1996 Dec;48(6A Suppl):23-32. doi: 10.1016/s0090-4295(96)00606-1.
5
Some analytical considerations on the measurement of prostate-specific antigen.关于前列腺特异性抗原测量的一些分析考量
Eur J Clin Chem Clin Biochem. 1996 Oct;34(10):817-21. doi: 10.1515/cclm.1996.34.10.817.
6
Abbott IMx evaluated for assay of prostate-specific antigen in serum.对雅培IMx检测血清中前列腺特异性抗原的方法进行评估。
Clin Chem. 1992 Oct;38(10):2140-2.
7
Comparative study of assays for prostate-specific antigen molecular forms.前列腺特异性抗原分子形式检测方法的比较研究
Jpn J Clin Oncol. 1999 Jun;29(6):303-7. doi: 10.1093/jjco/29.6.303.
8
Assay variability in serum prostate-specific antigen determination.血清前列腺特异性抗原测定中的检测变异性。
Prostate. 1995 Jul;27(1):1-6. doi: 10.1002/pros.2990270102.
9
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.使用AxSYM系统对413名因前列腺评估前来就诊的男性进行“反射范围”及游离前列腺特异性抗原百分比合适切点的测定。
Urology. 1997 Jan;49(1):19-27. doi: 10.1016/S0090-4295(96)00511-0.
10
Performance evaluation of a new chemiluminescent assay for prostate specific antigen.一种新型前列腺特异性抗原化学发光检测法的性能评估
J Clin Lab Anal. 2000;14(4):164-8. doi: 10.1002/1098-2825(2000)14:4<164::aid-jcla5>3.0.co;2-m.

引用本文的文献

1
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.抗原特异性体细胞等位基因突变和剪接变异的存在不能预测基因疫苗接种的免疫反应。
J Immunother Cancer. 2013 May 29;1:2. doi: 10.1186/2051-1426-1-2. eCollection 2013.
2
Clinical implications of introducing a new PSA assay.引入一种新的前列腺特异性抗原检测方法的临床意义。
Int Urol Nephrol. 2008;40(3):657-61. doi: 10.1007/s11255-007-9330-7. Epub 2008 Feb 6.